| Active substance |
Sibutramine, Clenbuterol, Vitamin D3, Vitamin E |
| Also known as |
Sibutramine hydrochloride monohydrate |
| Blood pressure |
Can increase blood pressure |
| Chemical name |
N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine hydrochloride monohydrate |
| Dosage (medical) |
Typically 10 mg once daily, may increase to 15 mg if insufficient weight loss |
| Dosage (sports) |
Not recommended for use in sports |
| Effects |
Weight loss, appetite suppression |
| Formula |
C17H26ClNВ·HClВ·H2O |
| Half-life |
1.1 hours (sibutramine), 14-16 hours (active metabolites M1 and M2) |
| Hepatotoxicity |
Low risk, but caution advised in patients with pre-existing liver conditions |
| Lab Test |
Blood levels can be measured, though not routinely done |
| Main action |
Reduction in calorie intake by inducing satiety |
| Side effects |
Dry mouth, insomnia, constipation, increased heart rate |
| Storage conditions |
Store at room temperature, keep away from moisture and heat |
| Substance class |
Serotonin-norepinephrine reuptake inhibitor (SNRI) |
| Trade name |
Meridia, Reductil |
| Use in sports |
Not commonly used due to potential side effects and banned status in many sports |
| Water Retention |
No significant effect |
| Active ingredient, mg |
Sibutramine - 3 mg, Clenbuterol - 0,05 mg, Vitamin D3 - 400 IU, Vitamin E - 75 IU |
| Release form |
Pills |
| 1 Pill, mg |
Sibutramine - 3 mg, Clenbuterol - 0,05 mg, Vitamin D3 - 400 IU, Vitamin E - 75 IU |
| Manufacturer |
Vital Research |
| Packing |
Pack (120 pills) |
